It was highlight point 2 that spoke to me ...
Patients with a higher level of T cell diversity inperipheral blood (pre-treatment) respond better to VAXINIA therapy, consistentwith the known mechanism of action of oncolytic virotherapies and their abilityto promote an anti-tumour T cell response.
This speaks to MoA and again basically proves that our virus is very effective.
We know that T-cell diversity is a positive as it helps immune defence in 2 ways ...• it means the patient has a strong pool of efficient T cells (which will be used in the ‘attack’)
• and it is flexible enough to ‘short-circuit’ an attempt at mutation.
This data will inform future expansions.
As others have said ... the next data cut may be left to YF to unveil. Time will tell ... soon I think.
Just my quick thoughts.
- Forums
- ASX - By Stock
- Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
It was highlight point 2 that spoke to me ...Patients with a...
-
- There are more pages in this discussion • 268 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $527.0M |
Open | High | Low | Value | Volume |
7.2¢ | 7.4¢ | 7.1¢ | $369.4K | 5.125M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 437887 | 7.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.2¢ | 1283493 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
30 | 2150424 | 0.071 |
31 | 1797257 | 0.070 |
19 | 1162759 | 0.069 |
28 | 1634578 | 0.068 |
20 | 2330855 | 0.067 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 1246004 | 13 |
0.073 | 1751356 | 17 |
0.074 | 1249178 | 12 |
0.075 | 705734 | 10 |
0.076 | 1016676 | 10 |
Last trade - 11.12am 15/05/2024 (20 minute delay) ? |
|
|||||
Last
7.1¢ |
  |
Change
0.000 ( 1.25 %) |
|||
Open | High | Low | Volume | ||
7.2¢ | 7.3¢ | 7.1¢ | 3044932 | ||
Last updated 11.29am 15/05/2024 ? |
Featured News
IMU (ASX) Chart |